1,572
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden

, , , &
Pages 198-206 | Received 28 Jun 2017, Accepted 27 Mar 2018, Published online: 06 Apr 2018

References

  • Endres DB. Investigation of hypercalcemia. Clin Biochem. 2012;45:954–963.
  • Nordenstrom E, Katzman P, Bergenfelz A. Biochemical diagnosis of primary hyperparathyroidism: Analysis of the sensitivity of total and ionized calcium in combination with PTH. Clin Biochem. 2011;44:849–852.
  • Dalemo S, Hjerpe P, Ohlsson H, et al. Variation in plasma calcium analysis in primary care in Sweden – a multilevel analysis. BMC Fam Pract. 2010;11:43.
  • Lindstedt G, Nystrom E, Lundberg PA, et al. Screening of an elderly population in primary care for primary hyperparathyroidism. Scand J Prim Health Care. 1992;10:192–197.
  • Applewhite MK, Schneider DF. Mild primary hyperparathyroidism: a literature review. Oncologist. 2014;19:919–929.
  • Dalemo S, Eggertsen R, Hjerpe P, et al. Quality of life and health care consumption in primary care patients with elevated serum calcium concentrations in-a prospective, case control, study. BMC Fam Pract. 2014;15:84.
  • Khosla S, Melton LJ, 3rd, Wermers RA, et al. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res. 1999;14:1700–1707.
  • Sankaran S, Gamble G, Bolland M, et al. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab. 2010;95:1653–1662.
  • Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561–3569.
  • Udelsman R, Akerstrom G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3595–3606.
  • Svedbom A, Hernlund E, Ivergard M, et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137.
  • Swedish National Guidelines for Musculoskeletal Diseases. The National Board of Health and Welfare. 2012, up-date 2014. Available from: www.socialstyrelsen.se (last accessed at 15 May 2017).
  • Looker AC, Orwoll ES, Johnston CC, Jr., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761–1768.
  • Blivik J, Karlsson MK, Moller M. Screening for low bone mineral density with quantitative ultrasound within the primary health care system. Scand J Prim Health Care. 2004;22:78–82.
  • Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25:2359–2381.
  • Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4:46–56.
  • Zeytinoglu M, Jain RK, Vokes TJ. Vertebral fracture assessment: enhancing the diagnosis, prevention, and treatment of osteoporosis. Bone. 2017;104:54–65.
  • Hagstrom E, Lundgren E, Mallmin H, et al. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Intern Med. 2006;259:191–198.
  • Almqvist EG, Becker C, Bondeson AG, et al. Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery. 2004;136:1281–1288.
  • Sutlovic D, Boric I, Sliskovic L, et al. Bone mineral density of skeletal remains: discordant results between chemical analysis and DXA method. Leg Med (Tokyo). 2016;20:18–22.
  • Dalemo S, Eggertsen R, Hjerpe P, et al. Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care. Scand J Prim Health Care. 2013;31:248–254.
  • Stam H, Harting T, van der Sluijs M, et al. Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch. general practice. Scand J Prim Health Care. 2016;34:165–171.
  • Dalemo S, Hjerpe P, Bostrom Bengtsson K. Diagnosis of patients with raised serum calcium level in primary care, Sweden. Scand J Prim Health Care. 2006;24:160–165.
  • Adami S, Braga V, Squaranti R, et al. Bone measurements in asymptomatic primary hyperparathyroidism. Bone. 1998;22:565–570.
  • SBU. Mätning av bentäthet (Measurement of bone mineral density). In: Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU-rapport 127; 1995.
  • Henneicke H, Gasparini SJ, Brennan-Speranza TC, et al. Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metab. 2014;25:197–211.
  • Canalis E, Mazziotti G, Giustina A, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319–1328.
  • Panday K, Gona A, Humphrey MB. Medication-induced osteoporosis: screening and treatment strategies. Therapeut Adv Musculoskeletal Dis. 2014;6:185–202.
  • Chen H. Primary Hyperparathyroidism. In: Cameron AM, editors. Current surgical therapy. Philadelphia (PA): Elsevier Saunders; 2011. p. 787–792.
  • Thörneby A, Nordeman LM, Hellebö Johanson E, No association between level of vitamin D and chronic low back pain in Swedish primary care: a cross-sectional case-control study. Scand J Prim Health Care. 2016;34:196–204.